DEVELOP
Growth innovative SMBs action plan
GD¤co, ¤conomic Development Group
GD€co, the €conomic Development Group, aims to reflect on actions and tools that Lyonbiopole has to implement in order to support SMBs development. The GD€co also makes recommendations which will be implemented after approval by the Board of Directors.
There are 15 people “intuitu personae” involved in the support to company’s development and committed to Lyonbiopole: Cécile Réal, Ariana Pharma - Fabrice Plasson, young entrepreneur in Amoéba - François Miceli, Imaxio - François Roy, Créalys - François Valencony, Mérieux Développement - Gilles Alberici, Orega Biotech - Grégoire Franoux, Flamel Technologies - Hélène Rouquette, IDD-Tech - Karine Lignel, Vizille Capital Innovation - Laurent Buffat, Altrabio - Nadia Kamal, Créalys - Nicolas Pasqual, ImmunID - Sandra Dubos, Oseo - Stéphane Legastelois, Indicia Biotechnology - Thierry Abribat, Alizé Pharma - Tristan Rousselle, PX Therapeutics.
The GD€co meets every 3 to 4 months.
More information
They speak about...
« The strategy implemented by Lyonbiopole in this area demonstrates great consistency with the level of excellence the cluster has set for itself. Today, Lyonbiopole is driving implementation of a process that brings together French clusters in the sector for greater visibility in the international arena. The agreements signed by the Lifescience Corridor with the Kansai and Massachusetts clusters in 2008 attest to the pertinence of this strategy. »
Alain Griot
DGCIS – Ministry of the Economy, Finance and Industry. Currently Assistant Manager of Innovation at the General Commission for Sustainable Development. (MEEDDAT) - Manager of the Technological Partnerships Office